RESUMO
Toxoplasma gondii is a protozoan that has great genetic diversity and is prevalent worldwide. In 2018, an outbreak of toxoplasmosis occurred in Santa Maria, Brazil, which was considered the largest outbreak ever described in the world. This paper describes the isolation and molecular characterization of Toxoplasma gondii from the placenta of two pregnant women with acute toxoplasmosis who had live births and were receiving treatment for toxoplasmosis during the outbreak. For this, placental tissue samples from two patients underwent isolation by mice bioassay, conventional PCR and genotyping using PCR-RFLP with twelve markers. Both samples were positive in isolation in mice. The isolate was lethal to mice, suggesting high virulence. In addition, the samples were positive in conventional PCR and isolates submitted to PCR-RFLP genotyping presented an atypical genotype, which had never been described before. This research contributes to the elucidation of this great outbreak in Brazil.
Assuntos
Coccidiostáticos/uso terapêutico , Placenta/parasitologia , Complicações Infecciosas na Gravidez/tratamento farmacológico , Toxoplasma/genética , Toxoplasmose/tratamento farmacológico , Animais , Brasil/epidemiologia , Modelos Animais de Doenças , Surtos de Doenças , Feminino , Genótipo , Humanos , Leucovorina/uso terapêutico , Nascido Vivo , Camundongos , Polimorfismo de Fragmento de Restrição , Gravidez , Complicações Infecciosas na Gravidez/epidemiologia , Complicações Infecciosas na Gravidez/parasitologia , Pirimetamina/uso terapêutico , Sulfadiazina/uso terapêutico , Toxoplasma/isolamento & purificação , Toxoplasmose/epidemiologia , Toxoplasmose/parasitologiaRESUMO
Infestations of Rhipicephalus microplus cause significant damage to cattle breeding and their control is primarily based on chemical products. There are extensive reports of efficacy losses of acaricid products over time, as well as resistance of the parasites to them, thereby making it necessary to search for new alternatives. The present work aimed to determine the in vitro and in vivo acaricidal activity of organo-modified siloxanes with and without piperonyl butoxide (PBO) in southern Brazil. For the in vitro test, engorged females of R. microplus were collected and submitted to the immersion test. The formulation containing organo-modified siloxanes was tested at 4 different concentrations: 0.6, 1.0, 2.5, and 5.0%. The lowest dilutions (0.6, 1.0, and 2.5%) were also tested with the inclusion of 10% PBO. The in vivo test was performed by applying 2.5% organo-modified siloxanes, and the addition of 10% PBO was applied by spraying. The results showed high acaricidal activity (100%) in vitro in the concentration of 5% on non-associated forms, and in combinations of concentrations of 0.6, 1.0, 2.5% with PBO. The in vivo results also increased the efficacy with the association of PBO. In view of the current multi-resistance scenario of the R. microplus tick to the different commercially available acaricidal products, this study investigated the use of this product in association with PBO as an alternative to R. microplus control and found positive results. To the authors' knowledge, this is the first study to use organo-modified siloxanes against ticks.